Skip to main content
. 2024 Mar 27;47(10):2449–2459. doi: 10.1007/s40618-024-02354-x

Table 1.

The diagnostic accuracy of screening tests stratified for disease aetiology

Test AUC
(95% CI)
Sensitivity
(95% CI)
Specificity
(95% CI)
Positive likelihood ratio Negative likelihood ratio Positive predictive value Negative predictive value
Cases vs controls
 LNSC

0.76

(0.65–0.87)

p < 0.001

87.5%

(73.2–95.8)

71.1%

(73.2–95.8)

2.49 0.19 76.1% 84.3%
 LNSE

0.79

(0.66–0.92)

p < 0.001

55.8%

(37.9–72.8)

96.1%

(80.4–99.9)

14.53 0.46 95.0% 62.5%
 ODST

0.74

(0.59–0.88)

p = 0.020

94.7%

(82.2–99.3)

52.1%

(30.6–73.2)

1.98 0.10 76.6% 85.7%
 LDDST

0.85

(0.69–1.0)

p < 0.001

97.4%

(86.5–99.9)

72.7%

(39.0–94.0)

3.57 0.04 92.7% 88.9%
 UFC

0.59

(0.43–0.76)

p = 0.260

60.0%

(43.3–75.1)

58.0%

(32.9–81.6)

1.46 0.68 77.4% 38.5%
CD vs controls
 LNSC

0.82

(0.72–0.93)

p < 0.001

100%

(80.5–100)

64.9%

(47.5–79.8)

2.85 0.00 56.7% 100%
 LNSE

0.93

(0.83–1.00)

p < 0.001

86.7%

(59.5–98.3)

96.1%

(80.4–99.9)

22.53 0.14 92.9% 92.6%
 ODST

0.71

(0.55–0.87)

p = 0.03

88.9%

(65.3–96.6)

52.2%

(30.6–73.2)

1.86 0.21 59.3% 85.7%
 LDDST

0.86

(0.70–1.0)

p = 0.001

100%

(84.6–100)

72.7%

(39.0–94.0)

3.67 0.00 88.0% 100%
 UFC

0.75

(0.58–0.91)

p = 0.008

90.9%

(70.8–98.9)

58.8%

(32.9–81.6)

2.21 0.15 74.1% 83.3%
MACS vs controls
 LNSC

0.71

(0.57–0.85)

p = 0.007

77.2%

(54.6–92.2)

64.8%

(47.5–79.8)

2.20 0.3 56.7% 82.8%
 LNSE

0.66

(0.47–0.85)

P = 0.102

27.8%

(9.7–53.5)

96.1%

(80.4–99.9)

7.22 0.75 83.3% 65.8%
 ODST

0.76

(0.66–1.00)

p = 0.004

100%

(82.4–100.0)

52.2%

(30.6–73.2)

2.09 0.00 63.3% 100%
 LDDST

0.83

(0.66–1.00)

p = 0.004

93.8%

(69.8–99.8)

72.7%

(39.0–94.0)

3.44 0.09 83.3% 88.9%
 UFC

0.62

(0.43–0.80)

p = 0.242

17.7%

(3.8–43.4)

58.8%

(32.9–81.6)

0.43 1.4 30.0% 41.7%

LNSC late-night salivary cortisol, LNSE late-night salivary cortisone, ODST overnight dexamethasone test, LDDST low-dose (2 mg) dexamethasone test, UFC 24 h urinary free cortisol. CD Cushing’s disease, MACS mild autonomous cortisol secretion